
样式: 排序: IF: - GO 导出 标记为已读
-
Interferon regulatory factor-1–expressing astrocytes are epigenetically controlled and exacerbate TBI-associated pathology in mice Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-28
Wenxing Cui, Hao Bai, Chengxuan Guo, Jinpeng Zhou, Dayun Feng, Shiji Zhang, Fei Gao, Liying Han, Yang Tian, Jingyu Dong, Feilong Wei, Jian Bai, Xun Wu, Yingwu Shi, Hao Guo, Liang Wang, Zhihong Li, Wei Guo, Tianzhi Zhao, Lijun Heng, Qing Cai, Haixiao Liu, Shunnan Ge, Yan QuAstrocyte heterogeneity is closely associated with the pathophysiology of traumatic brain injury (TBI), particularly in the development of cerebral edema, which is a major contributor to morbidity and mortality in patients with TBI. However, little is known about how certain astrocyte subpopulations contribute to the development of cerebral edema after acute brain injury. Using multiomics approaches
-
Anti-inflammatory, but not lipid-lowering, activity of hepatocyte PPARα improves atherosclerosis in Ldlr- deficient mice Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-28
Doriane Henry, Eric Baugé, Nathalie Hennuyer, Kevin Ory, Bruno Derudas, Emmanuelle Vallez, Audrey Deprince, Philippe Lefebvre, Joel T. Haas, Bart Staels, Fanny LalloyerAtherogenic dyslipidemia and chronic inflammation appear strongly associated with residual cardiovascular disease (CVD) risk. Peroxisome proliferator–activated receptor α (PPARα) agonists, which exert both triglyceride-lowering and anti-inflammatory properties, are potential therapeutic candidates to target residual CVD risk. However, CVD outcome studies with these drugs have yielded mixed results
-
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-28
Beatrice Greco, Rita El Khoury, Chiara Balestrieri, Camilla Sirini, Alice Machado, Federica De Girardi, Laura De Rossi, Oronza Antonietta Botrugno, Giulio Giovannoni, Laura Falcone, Barbara Camisa, Elena Tiziano, Katia Palmisano, Edoardo Campodonico, Marta Angiola Moresco, Laura Perani, Alice Bergamini, Amanda Facoetti, Federica Ungaro, Giovanni Tonon, Emmanuel Donnadieu, Claudio Doglioni, Fabio CiceriLiver metastases represent the leading cause of death in patients with colorectal cancer (CRC). Chimeric antigen receptor (CAR) T cell therapy holds promise in this context, but any effort to bring it to the bedside requires careful antigen selection and testing in clinically relevant models. Here, we identified cadherin-17 (CDH17) as a candidate antigen for CAR T cell therapy of CRC liver metastases
-
Peripherally induced RORγt + skin-resident regulatory T cells mediate the efficacy of allergen-specific immunotherapy Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-28
KeLun Zhang, Su Min Kim, Ho-Keun Kwon, Seo Hyeong Kim, Tae-Gyun Kim, ZhengWang Sun, Hye Li Kim, Alina Tyo, Ji Hye Kim, Ryeo Won Kim, Jong Hoon Kim, Je-Min Choi, Kyung Min Park, Lark Kyun Kim, Myung Hyun Sohn, Jung-Won Park, Kwang Hoon Lee, Thomas S. Kupper, Chang Ook ParkSkin-resident regulatory T cells (T reg cells) cells play a critical role in subcutaneous allergen-specific immunotherapy (SIT) for atopic dermatitis (AD). However, a detailed description of the phenotype and origin of skin-resident T reg cells during SIT is lacking. Therefore, we investigated the role and origin of specific T reg lineages in SIT with human AD samples and with a mouse model of AD.
-
Gasdermin D drives the systemic storm and mortality after trauma with hemorrhage to a greater degree in biological females than males Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-28
Xuejing Sun, Sultan S. Abdelhamid, Zachary Secunda, Robert Voinchet, Alyssa Gregory, Jacob Scioscia, Mehves Ozel, Jennifer L. Darby, Hamed Moheimani, Qing-De Wang, Jishnu Das, Matthew D. Neal, Upendra K. Kar, Jason L. Sperry, Timothy R. BilliarSevere injury accompanied by hemorrhagic shock triggers an early release of cell constituents into the circulation, referred to as the systemic storm. The systemic storm drives the systemic inflammatory response and is associated with increased mortality. The role of programmed cell death (PCD) in the systemic storm was investigated in mice that underwent hemorrhagic shock with tissue trauma (HS/T)
-
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-28
Giusy De Rosa, Claudia Russo, Silvia Garavelli, Dario Di Silvestre, Ilaria Spatocco, Giorgia Mele, Claudia La Rocca, Alessandra Colamatteo, Fortunata Carbone, Clorinda Fusco, Fabiana Passaro, Donatella Carpi, Elena Tagliabue, Francesco Prattichizzo, Francesca Brambilla, Pierluigi Mauri, Mirjam Hoxha, Valentina Bollati, Ilaria Giusti, Vincenza Dolo, Paola D’Antona, Paola Campomenosi, Valentina MangoliniCD4 + CD25 hi FoxP3 + regulatory T cells (T reg cells) are key controllers of immune self-tolerance, and their suppressive function is impaired in people with relapsing-remitting multiple sclerosis (pwRR-MS). Because the mechanisms underlying this condition are still ill-defined, we investigated the role of T reg cell–derived extracellular vesicles (T reg -EVs) in T reg cell dysfunction observed in
-
Icosapent ethyl reduces arterial thrombosis by inhibition of cyclooxygenase-1–induced platelet reactivity Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-21
Philipp Mourikis, Marcel Benkhoff, Laura Wildeis, Maike Barcik, Carolin Helten, Cristina Coman, Fiorella A. Solari, Daniel Krahn, Lisa Dannenberg, Samantha Ahlbrecht, Dorothee Zikeli, Amelie Utz, Kajetan Trojovsky, Hannah Richter, Gabrielle Al Kassis, René M’Pembele, Saif Zako, Tim Huckenbeck, Sofia Bauer, Danny Schmitz, Susanne Pfeiler, Norbert Gerdes, Christof Dücker, Joachim Pircher, Zhang Zhe,Large, randomized trials testing omega-3 polyunsaturated fatty acid (ω-3 PUFA) supplementation to reduce cardiovascular events have reported contradictory results. Interpretation of these trials is challenging, because different dosages and formulations of ω-3 PUFA were tested. Furthermore, the exact mechanisms for the reduction in cardiovascular events are unclear. In this study, we investigated the
-
Islet transplantation in immunomodulatory nanoparticle–remodeled spleens Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-21
Mi Liu, Huiming Deng, Chunyan Liu, Lintao Wang, Zhongkai Liao, Desheng Li, Yan Chen, Jianhui Li, Jianhui Dong, Xuyong Sun, Chunming Wang, Ling Huang, Lei Dong, Jian XiaoIslet transplantation is a promising therapy for insulin-dependent diabetes. However, immune rejection and insufficient vascularization hinder the survival and function of transplanted islets. Here, we show effective engraftment of vascularized and functional mouse and rat islets transplanted into biomaterial-remodeled spleens of nonimmunosuppressed rodents and human islets transplanted into the remodeled
-
In vivo CRISPR activation screen identifies acyl-CoA–binding protein as a driver of bone metastasis Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-21
Hongqi Teng, Qinglei Hang, Caishang Zheng, Yuelong Yan, Shaomin Liu, Yang Zhao, Yalan Deng, Litong Nie, Weiche Wu, Marisela Sheldon, Zachary Yu, Wei Shi, Jianxuan Gao, Chenling Meng, Consuelo Martinez, Jie Zhang, Fan Yao, Yutong Sun, Di Zhao, Boyi Gan, Tong Meng, Li MaOne of the most common sites of cancer metastasis is to the bone. Bone metastasis is associated with substantial morbidity and mortality, and current therapeutic interventions remain largely palliative. Metastasizing tumor cells need to reprogram their metabolic states to adapt to the nutrient environment of distant organs; however, the role and translational relevance of lipid metabolism in bone metastasis
-
Human monoclonal antibodies targeting subdominant meningococcal antigens confer cross-protection against gonococcus Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-21
Marco Troisi, Monica Fabbrini, Samuele Stazzoni, Viola Viviani, Filippo Carboni, Valentina Abbiento, Lucia Eleonora Fontana, Sara Tomei, Martina Audagnotto, Laura Santini, Angela Spagnuolo, Giada Antonelli, Ida Paciello, Fabiola Vacca, Dario Cardamone, Eleonora Marini, Pardis Mokhtary, Francesca Finetti, Fabiola Giusti, Margherita Bodini, Giulia Torricelli, Chiara Limongi, Mariangela Del Vecchio, SaraGonococcus, a bacterium resistant to most antibiotics, causes more than 80 million cases of gonorrhea annually and is considered a high-priority pathogen by the World Health Organization. Recently, vaccine development prospects were boosted by reports that licensed meningococcus serogroup B (MenB) vaccines provided partial protection against gonococcal infection. To determine antigens responsible for
-
SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19 Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-21
Leon L. Hsieh, Elizabeth A. Thompson, Nirvani P. Jairam, Katerina Roznik, Alexis Figueroa, Tihitina Aytenfisu, Weiqiang Zhou, Naina Gour, Kuan-Hao Chao, Aaron M. Milstone, Emily Egbert, Franco D’Alessio, Petros C. Karakousis, Alvaro Ordoñez, Eileen P. Scully, Andrew Pekosz, Andrew H. Karaba, Andrea L. CoxSevere COVID-19 presents with a distinct immunological profile, characterized by elevated neutrophil and reduced lymphocyte counts, seen commonly in fungal and bacterial infections. This study demonstrates that patients hospitalized with COVID-19 show evidence of neutrophil degranulation and have increased expression of neutrophil surface lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1)
-
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-21
Elena Grassi, Valentina Vurchio, George D. Cresswell, Irene Catalano, Barbara Lupo, Francesco Sassi, Francesco Galimi, Sofia Borgato, Martina Ferri, Marco Viviani, Simone Pompei, Gianvito Urgese, Bingjie Chen, Eugenia R. Zanella, Francesca Cottino, Mariangela Russo, Gianluca Mauri, Filippo Pietrantonio, Maria Giulia Zampino, Luca Lazzari, Silvia Marsoni, Alberto Bardelli, Marco Cosentino LagomarsinoHistorically, DNA sequence mutability has been considered relatively uniform and low in tumors with chromosomal instability (CIN), based on the assumption that high mutability would be detrimental in karyotypically aberrant contexts. Recent in silico analyses have challenged this view, suggesting some heterogeneity in mutation rates across CIN tumors; however, these predictions lack experimental validation
-
Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophy Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-14
Beltran Borges, Stephen M. Brown, Wan-Jin Chen, Maria T. Clarke, Akos Herzeg, Jae Hong Park, Joshua Ross, Lingling Kong, Madeline Denton, Amy K. Smith, Tony Lum, Fareha Moulana Zada, Marco Cordero, Nalin Gupta, Sarah E. Cook, Heather Murray, John Matson, Stephanie Klein, C. Frank Bennett, Adrian R. Krainer, Tippi C. MacKenzie, Charlotte J. SumnerNeurological disorders with onset before or at birth are a leading cause of morbidity and mortality in infants and children. Prenatal treatment has the potential to reduce or prevent irreversible neuronal loss and facilitate normal neurodevelopment. We hypothesized that antisense oligonucleotides (ASOs) delivered to the amniotic fluid by intra-amniotic (IA) injection could safely distribute to the
-
Expanded T cell clones with lymphoma driver somatic mutations accumulate in refractory celiac disease Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-14
Mandeep Singh, Raymond H. Y. Louie, Jerome Samir, Matthew A. Field, Claire Milthorpe, Thiruni Adikari, Joseph Mackie, Ellise Roper, Megan Faulks, Katherine J. L. Jackson, Andrew Calcino, Melinda Y. Hardy, Piers Blombery, Timothy G. Amos, Ira W. Deveson, Helen Vander Wende, Stephen N. Floor, Scott A. Read, Dmitri Shek, Antoine Guerin, Cindy S. Ma, Stuart G. Tangye, Antonio Di Sabatino, Marco V. LentiIntestinal inflammation continues in a subset of patients with celiac disease despite a gluten-free diet. Here, by applying multi-omic single-cell analysis to duodenal biopsies, we found that low-grade malignancies with lymphoma driver mutations in patients with refractory celiac disease type 2 (RCD2) are comprised by surface CD3-negative (sCD3 − ) lymphocytes stalled at an innate lymphoid cell (ILC)–progenitor
-
An AAV variant selected through NHP screens robustly transduces the brain and drives secreted protein expression in NHPs and mice Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-14
Luis Tecedor, Yong Hong Chen, David E. Leib, Paul T. Ranum, Megan S. Keiser, Brian C. Lewandowski, Elli M. Carrell, Elena Lysenko, Icnelia Huerta-Ocampo, Sakshi Arora, Congsheng Cheng, Xueyuan Liu, Beverly L. DavidsonRecent work has shown that prolonged expression of recombinant proteins after adeno-associated virus (AAV)–mediated delivery of gene therapy to long-lived, ventricle-lining ependymal cells can profoundly affect disease phenotypes in animal models of neurodegenerative diseases. Here, we performed in vivo screens of millions of peptide-modified capsid variants of AAV1, AAV2, and AAV9 parental serotypes
-
An oral norovirus vaccine generates mucosal immunity and reduces viral shedding in a phase 2 placebo-controlled challenge study Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-14
Becca A. Flitter, Joshua Gillard, Susan N. Greco, Maria D. Apkarian, Nick P. D’Amato, Lam Quynh Nguyen, Elena D. Neuhaus, Darreann Carmela M. Hailey, Marcela F. Pasetti, Mallory Shriver, Christina Quigley, Robert W. Frenck, Lisa C. Lindesmith, Ralph S. Baric, Lee-Jen Wei, Sean N. Tucker, James F. CummingsThere are currently no licensed vaccines for norovirus, a leading cause of epidemic and endemic gastroenteritis worldwide. Clinical advancement of promising vaccine candidates from phase 2 studies to phase 3 field trials has been hampered by the lack of robust immunological correlates of protection. Here, we conducted a phase 2b randomized, placebo-controlled vaccination and challenge study to assess
-
MEK1/2 inhibitors suppress pathological α-synuclein and neurotoxicity in cell models and a humanized mouse model of Parkinson’s disease Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-14
Huilan Wang, Qing Wang, Haoxiang Xu, Yuanzheng Wu, Siulam Cheung, Qianhui Xu, Chengfang Pan, Jingyu Cao, Zhiyuan Cao, Ruonan Yang, Yu Ding, Yiyan Fei, Yongfeng Chen, Jian Wang, Cong Liu, Boxun LuThe abnormal accumulation of misfolded proteins is a common hallmark of many neurodegenerative disorders. Among these proteins, α-synuclein (αsyn) is a well-characterized pathogenic protein in Parkinson’s disease (PD) and other synucleinopathies. αsyn can be hyperphosphorylated and form pathological aggregates, leading to neurodegeneration. Thus, chemical modulators of pathological αsyn may suppress
-
Rapid closure and hemostasis of ruptured soft tissues using a modified human tropoelastin-based sealant in preclinical models Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-14
Mahsa Ghovvati, Saumya Jain, George Z. Cheng, Naoki Kaneko, Joshua A. Boys, Taichiro Imahori, Tess De Maeseneer, Reihaneh Haghniaz, Robert B. Cameron, Anthony S. Weiss, Nasim AnnabiTreatment of injuries to soft elastic organs is often hindered by challenging anatomical features and limitations of existing sealant materials, which may lack adequate tissue adhesion, elasticity, biocompatibility, and effective hemostatic properties. To address these clinical challenges, we developed an injectable elastic sealant formulated with methacryloyl-modified human recombinant tropoelastin
-
-
Patient-derived models of UBA5- associated encephalopathy identify defects in neurodevelopment and highlight potential therapeutic avenues Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-07
Helen Chen, Christy W. LaFlamme, Yong-Dong Wang, Aidan W. Blan, Nikki Koehler, Renata Mendonca Moraes, Athena R. Olszewski, Edith P. Almanza Fuerte, Emily S. Bonkowski, Richa Bajpai, Alfonso Lavado, Shondra M. Pruett-Miller, Heather C. MeffordUBA5 encodes for the E1 enzyme of the UFMylation cascade, which plays an essential role in endoplasmic reticulum (ER) homeostasis. The clinical phenotypes of UBA5 -associated encephalopathy include developmental delays, epilepsy, and intellectual disability. To date, there is no humanized neuronal model to study the cellular and molecular consequences of UBA5 pathogenic variants. We developed and characterized
-
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-07
Jiahao Liu, Xiaofei Jiao, Wei Mu, Huayi Li, Yu Xia, Yijie Wu, Li Zhu, Qing Zhong, Wen Pan, Xingzhe Liu, Minghua Xiang, Jiali Cheng, Haolong Lin, Xuejiao Zhao, Zhiyong Ding, Guang Hu, Gordon B. Mills, Ding Ma, Qinglei Gao, Yong FangPoly(ADP-ribose) polymerase inhibitors (PARPis) are a class of agents targeting DNA damage repair that have become standard therapy for epithelial ovarian cancer (EOC) and multiple other solid tumors. In addition to targeting DNA damage repair, PARPis actively modulate antitumor immune responses, with efficacy being partially dependent on T cell activity. Here, we found that patient T cells sustain
-
The inhibitory receptor Siglec-E controls antigen-presenting cell activation and T cell–mediated transplant rejection Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-07
Thiago J. Borges, Karina Lima, Rodrigo B. Gassen, Kaifeng Liu, Yoshikazu Ganchiku, Guilherme T. Ribas, Minxue Liao, Joao I. B. Goncalves, Isadora T. Lape, Ivy A. Rosales, Yunlong Zhao, Enfu Hui, Robert L. Fairchild, Christian LeGuern, Cristina Bonorino, Stuart K. Calderwood, Joren C. Madsen, Leonardo V. RiellaAfter transplantation, inflammation and tissue injury release danger signals that activate myeloid cells, driving adaptive immune responses and acute rejection. Current immunosuppressants primarily target T cells but inadequately control innate immunity. Regulatory signals controlling innate responses in transplantation remain elusive. The sialic acid–binding immunoglobulin-like lectin-E (Siglec-E
-
Splicing regulatory dynamics for precision analysis and treatment of heterogeneous leukemias Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-07
Meenakshi Venkatasubramanian, Leya Schwartz, Nandini Ramachandra, Joshua Bennett, Krithika R. Subramanian, Xiaoting Chen, Shanisha Gordon-Mitchell, Ariel Fromowitz, Kith Pradhan, David Shechter, Srabani Sahu, Diane Heiser, Peggy Scherle, Kashish Chetal, Aishwarya Kulkarni, Davy Lee, Jeff Zhou, Kasiani C. Myers, Elizabeth Tseng, Matthew T. Weirauch, H. Leighton Grimes, Daniel T. Starczynowski, AmitThe role of splicing dysregulation in cancer is underscored by splicing factor mutations; however, its impact in the absence of such rare mutations remains poorly understood. Prompted by the finding that splicing uniquely resolved genetic subtypes of cancer, we developed an unsupervised computational workflow called OncoSplice to comprehensively define tumor molecular landscapes. In adult and pediatric
-
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-07
Christina Dold, Blanché Oguti, Laura Silva-Reyes, Anna Stanzelova, Meriel Raymond, Catherine C. Smith, Maria Moore, Anna Barton, Edward M. Choi, Emma Plested, Kiarash Tanha, Jennifer Louth, Ann Holland, Robert Cook, Jessica King, Jay Lucidarme, Ray Borrow, Adrian V. S. Hill, Peter T. Beernink, Xinxue Liu, Andrew J. Pollard, Christine S. RollierCapsular group B meningococcus (MenB) remains an important cause of disease globally, and additional vaccines against MenB would aid in reducing the incidence of infection. Previous work has demonstrated that a MenB adenoviral-vectored vaccine, ChAdOx1 MenB.1, elicited high serum bactericidal responses in preclinical models after a single dose, supporting further clinical development of this vaccine
-
PET imaging of antisense oligonucleotide distribution in rat and nonhuman primate brains using click chemistry Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-07
Brendon E. Cook, Thomas C. Pickel, Sangram Nag, Philippe N. Bolduc, Rouaa Beshr, Anton Forsberg Morén, Cathy Muste, Giulia Boscutti, Di Jiang, Long Yuan, Prodip Datta, Piotr Ochniewicz, Yasir Khani Meynaq, Sac-Pham Tang, Christophe Plisson, Mario Amatruda, Qize Zhang, Jonathan M. DuBois, Armin Delavari, Stephanie K. Klein, Ildiko Polyak, Adebowale Shoroye, Sara Girmay, Christer Halldin, Laurent MartarelloDetermination of a drug’s biodistribution is critical to ensure that it reaches the target tissue of interest. This is particularly challenging in the brain, where invasive sampling methods may not be possible. Here, we present a pretargeted positron emission tomography (PET) imaging methodology that uses bioorthogonal click chemistry to determine the distribution of an antisense oligonucleotide (ASO)
-
Somatic mosaicism in the buccal mucosa reflects lifestyle and germline risk factors for esophageal squamous cell carcinoma Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-01
Akira Yokoyama, Koichi Watanabe, Yoshikage Inoue, Tomonori Hirano, Masashi Tamaoki, Kenshiro Hirohashi, Shun Kawaguchi, Yoshihiro Ishida, Yasuhide Takeuchi, Yo Kishimoto, Soo Ki Kim, Chikatoshi Katada, Yasuhito Nannya, Hiroshi Seno, Seishi Ogawa, Manabu Muto, Nobuyuki KakiuchiClones harboring cancer driver mutations can expand in normal tissues, known as somatic mosaicism, and can be influenced by age and environmental and germline factors. Somatic mosaicism in the blood predicts the risk of hematological malignancies; however, the relevance of somatic mosaicism to solid tumors remains unclear, in part because of limited sample availability. Lifestyle habits, including
-
Hypoxia-inducible factors link poor glycemic control to diabetic retinopathy Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-01
Yusuke Ichiyama, Przemyslaw SapiehaHypoglycemic episodes exacerbate diabetic eye disease, which is targetable by dual-HIF inhibition (Guo et al. , this issue).
-
A thin cryobiopsy device compatible with transnasal endoscopy for the gastrointestinal tract Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-01
David O. Otuya, Hamid Farrokhi, Yogesh Verma, Jing Dong, Peter Choy, Aditya Kumar, Rachel E. Shore, Sarah K. Zemlok, Evan Sevieri, Mason Schellenberg, Graham Spicer, Dan Rolando Lopez, Hany A. Osman, Joseph A. Gardecki, Alfred A. F. Kyrollos Kelada, Anna H. Gao, Anita Chung, Catriona N. Grant, Nitasha G. M. Bhat, Mireille Rosenberg, Brian C. Jacobson, Norman S. Nishioka, Yolonda Colson, Guillermo JLuminal organ biopsies are critical for disease diagnosis and are obtained using single-bite forceps inserted through the working channel of large endoscopes. Procedures using these endoscopes frequently require patient sedation or anesthesia and may not be feasible for use in pediatric patients. Additionally, forceps-derived biopsies can suffer from difficulty maintaining tissue orientation, crush
-
Objective autonomic signatures of tinnitus and sound sensitivity disorders Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-01
Samuel S. Smith, Kelly N. Jahn, Jenna A. Sugai, Kenneth E. Hancock, Daniel B. PolleyHypersensitivity, phantom percepts, and sensory reactivity are core features of many neurological disorders. Direct, objective measurements of these features have proven difficult to identify, leaving subjective questionnaires as the primary means of assessing sensory disorder severity. Here, we studied neurotypical adults ( n = 50) or adults with sound sensitivity and tinnitus (ringing of the ears)
-
Brain-wide microglia replacement using a nonconditioning strategy ameliorates pathology in mouse models of neurological disorders Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-01
Dadian Chen, Chen Wang, Xi Chen, Jiayu Li, Shuai Chen, Yanzhong Li, Fangling Ma, Tingting Li, Mengling Zou, Xin Li, Xiaohua Huang, Yun-wu Zhang, Yingjun Zhao, Guojun Bu, Honghua Zheng, Xiao-Fen Chen, Jie Zhang, Li ZhongGrowing genetic and pathological evidence has identified microglial dysfunction as a key contributor to the pathogenesis and progression of various neurological disorders, positioning microglia replacement as a promising therapeutic strategy. Traditional bone marrow transplantation (BMT) methods for replenishing brain microglia have limitations, including low efficiency and the potential for brain
-
Hypoglycemia promotes inner blood-retinal barrier breakdown and retinal vascular leakage in diabetic mice Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-01
Chuanyu Guo, Yueqi Niu, Xuemei Pan, Deepti Sharma, Evan Lau, Yang Jin, Guillaume Luxardi, Md Amanullah, Kevin Lo, Ala Moshiri, Jiang Qian, Silvia Montaner, Akrit SodhiThe blood-retinal barrier (BRB) serves as a physiological boundary regulating the passage of nutrients, waste, ions, proteins, and water to and from the retina. In patients with diabetic retinopathy, breakdown of the inner BRB (iBRB) results in damage to the neurovascular unit and is a principal cause of vision loss in the diabetic population. Here, we demonstrate that hypoglycemia, a common consequence
-
Inclusion of a retroviral protease enhances the immunogenicity of VLP-forming mRNA vaccines against HIV-1 or SARS-CoV-2 in mice Sci. Transl. Med. (IF 15.8) Pub Date : 2025-05-01
Peng Zhang, Mamta Singh, Vada A. Becker, Jacob Croft, Yaroslav Tsybovsky, Vinay Gopan, Yuna Seo, Qingbo Liu, Denise Rogers, Huiyi Miao, Yin Lin, Daniel Rogan, Courtney Shields, Sayda M. Elbashir, Samantha Calabrese, Isabella Renzi, Vladimir Preznyak, Elizabeth Narayanan, Guillaume Stewart-Jones, Sunny Himansu, Mark Connors, Kelly Lee, Andrea Carfi, Paolo LussoMessenger RNA (mRNA) has emerged as a highly effective and versatile platform for vaccine delivery. We previously designed a virus-like particle (VLP)–forming env-gag mRNA vaccine against human immunodeficiency virus–1 (HIV-1) that elicited envelope-specific neutralizing antibodies and protection from heterologous simian-human immunodeficiency virus (SHIV) infection in rhesus macaques. Here, we introduce
-
-
Activation and targetability of TYMP–IL-6–TF signaling in the skin microenvironment in uremic calciphylaxis Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-23
Marc Arthur Napoleon, Xiaosheng Yang, Yichi Zhang, Austin Morrissey, Scott Krinsky, Adam Lazowski, Houda Bouchouari, Abbas Malloum Brahim, Isaac Sellinger, Thierry Edwards, Asha Jose, Saran Lotfolhzadeh, Ricardo Almiron, Wenqing Yin, Jeffrey J. Siracuse, Jean Francis, Juliane Lokau, Christoph Garbers, Piqueras Maria Del Carmen, Vijaya B. Kolachalama, Ruben Dries, Rosalynn M. Nazarian, Sagar U. NigwekarCalciphylaxis is an orphan disease characterized by dermal microvessel thrombosis, inflicting painful cutaneous necrosis. It occurs predominantly in patients with end-stage kidney disease and has high mortality, elusive pathogenesis, and no approved therapies. We demonstrate that sera from patients with calciphylaxis induced de novo synthesis of interleukin-6 (IL-6) and soluble IL-6 receptor (IL-6R)
-
A high-resolution screen identifies a preexisting beta-lactam that specifically treats Lyme disease in mice Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-23
Maegan E. Gabby, Abey Bandara, L. M. Outrata, Osamudiamen Ebohon, Saadman S. Ahmad, Jules M. Dressler, Mecaila E. McClune, Rebecca N. Trimble, Lainey Mullen, Brandon L. JutrasLyme disease, caused by Borrelia burgdorferi in the United States, is an escalating human health problem that can cause severe disease if not properly treated. Doxycycline is the primary treatment option for Lyme disease; however, several concerns are associated with high-dose doxycycline treatment. For example, doxycycline is a broad-spectrum antibiotic and kills beneficial bacteria. Doxycycline is
-
The peptidoglycan of Borrelia burgdorferi can persist in discrete tissues and cause systemic responses consistent with chronic illness Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-23
Mecaila E. McClune, Osamudiamen Ebohon, Jules M. Dressler, Marisela M. Davis, Juselyn D. Tupik, Robert B. Lochhead, Carmen J. Booth, Allen C. Steere, Brandon L. JutrasPersistent symptoms after an acute infection is an emerging public health concern, but the pathobiology of such conditions is not well understood. One possible scenario involves the persistence of lingering antigen. We have previously reported that patients with postinfectious Lyme arthritis often harbor the peptidoglycan (PG) cell wall of Borrelia burgdorferi , the Lyme disease agent, in the synovial
-
A microfluidic wearable device for wound exudate management and analysis in human chronic wounds Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-23
Canran Wang, Kexin Fan, Ehsan Shirzaei Sani, José A. Lasalde-Ramírez, Wenzheng Heng, Jihong Min, Samuel A. Solomon, Minqiang Wang, Jiahong Li, Hong Han, Gwangmook Kim, Soyoung Shin, Alex Seder, Chia-Ding Shih, David G. Armstrong, Wei GaoChronic wounds are a major global health challenge associated with substantial economic burden and a negative impact on patient quality of life. Real-time analysis of biomarkers like reactive oxygen and nitrogen species could guide treatment, but existing systems lack the capacity required for continuous monitoring. Wound exudate is secreted slowly and has a complex composition, making efficient fluid
-
Glutathione-specific gamma–glutamylcyclotransferase 1 ( CHAC1 ) increases kidney disease risk by modulating ferroptosis Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-23
Lakshmi P. Kolligundla, Katie M. Sullivan, Dhanunjay Mukhi, Magaiver Andrade-Silva, Hongbo Liu, Yuting Guan, Xiangchen Gu, Junnan Wu, Tomohito Doke, Daigoro Hirohama, Paolo Guarnieri, Jon Hill, Steven S. Pullen, Jay Kuo, Masataka Inamoto, Katalin SusztakGenome-wide association studies (GWASs) have identified more than 1000 loci where genetic variants correlate with kidney function. However, the specific genes, cell types, and mechanisms influenced by these genetic variants remain largely uncharted. Here, we identified glutathione-specific gamma–glutamylcyclotransferase 1 ( CHAC1 ) on chromosome 15 as affected by GWAS variants by analyzing human kidney
-
FcγR binding differentially contributes to protection by two human monoclonal antibodies targeting Plasmodium falciparum circumsporozoite protein Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-23
Neville K. Kisalu, Lais D. Silva Pereira, Jonathan D. Herman, Mangaiarkarasi Asokan, Keenan Ernste, Jonah Merriam, Cuiping Liu, Megan E. DeMouth, Amarendra Pegu, Mariah Lofgren, Marlon Dillon, Brian Bonilla, Ryan MacVicar, Yonatan Zur, Patience Kiyuka, Yevel Flores-Garcia, Saborni Chakraborty, Daria Nikolaeva, Rodney Ogwang, Barbara Flynn, Joseph Francica, Theodore C. Pierson, Richard A. Koup, FidelAntibodies mediate protection against a wide range of pathogens through binding and neutralizing the pathogen or through Fc-mediated effector functions. Human monoclonal antibodies (mAbs) CIS43LS and L9LS show high-affinity binding targeting distinct regions on the Plasmodium falciparum circumsporozoite protein (PfCSP) and are highly effective in preventing malaria in humans. However, the role of FcγR
-
-
Liver-targeted allergen immunotherapy rapidly and safely induces antigen-specific tolerance to treat allergic airway disease in mice. Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-16
J Emiliano Gómez Medellín,Trevor W M Ung,Thomas Wang,Kevin Chang,Alexandra Cassano,Trevin Kurtanich,Joseph W Reda,Kristen E Shema,Nikola Stanic,Anna J Slezak,Ivan Vuong,Bohao Chen,Shijie Cao,Maria-Luisa Alegre,Melody A Swartz,Jeffrey A HubbellCurrent asthma treatments manage disease symptoms but fail to address the underlying cause of allergic disease. Allergen immunotherapy holds the promise for durable disease control by establishing allergen-specific tolerance through repeated introduction of native allergens; however, its efficacy can be limited by long interventions, reactions upon administration, and poor patient compliance. Here
-
Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-16
Kai R. Trepka, Wesley A. Kidder, Than S. Kyaw, Taylor Halsey, Christine A. Olson, Edwin F. Ortega, Cecilia Noecker, Vaibhav Upadhyay, Dalila Stanfield, Paige Steiding, Benjamin G. H. Guthrie, Peter Spanogiannopoulos, Darren Dumlao, Jessie A. Turnbaugh, Matthew D. Stachler, Erin L. Van Blarigan, Alan P. Venook, Chloe E. Atreya, Peter J. TurnbaughDose-limiting toxicities remain a major barrier to drug development and therapy, revealing the limited predictive power of human genetics. Here, we demonstrate the utility of a more comprehensive approach to studying drug toxicity through longitudinal profiling of the human gut microbiome during colorectal cancer (CRC) treatment (NCT04054908) coupled to cell culture and mouse experiments. Substantial
-
Pentatricopeptide repeat protein targeting CUG repeat RNA ameliorates RNA toxicity in a myotonic dystrophy type 1 mouse model Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-16
Takayoshi Imai, Maiko Miyai, Joe Nemoto, Takayuki Tamai, Masaru Ohta, Yusuke Yagi, Osamu Nakanishi, Hideki Mochizuki, Masayuki NakamoriMyotonic dystrophy type 1 (DM1) is an autosomal dominant multisystemic disorder caused by the expansion of a CTG-triplet repeat in the 3′ untranslated region of the dystrophia myotonica protein kinase ( DMPK ) gene. It results in the transcription of toxic RNAs that contain expanded CUG repeats (CUG exp ). Splicing factors, such as muscleblind-like 1 (MBNL1), are sequestered by CUG exp , thereby disrupting
-
Condensation of cellular prion protein promotes renal fibrosis through the TBK1-IRF3 signaling axis Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-16
Tantan Long, Yumei Lu, Yuanyuan Ma, Yandong Song, Xiaoping Yi, Xiaomei Chen, Miaomiao Zhou, Jingyi Ma, Jiayuan Chen, Zhuoliang Liu, Fengxin Zhu, Zheng Hu, Zhanmei Zhou, Chaoyang Li, Fan Fan Hou, Lirong Zhang, Yupeng Chen, Jing NieCellular prion protein (PrP C ), known for its pathological isoform in prion diseases such as Creutzfeldt-Jakob disease, is primarily expressed in the nervous system but has also been detected in the blood and urine of individuals with renal dysfunction. However, the role of PrP C in the development of renal disease is unexplored. Here, we showed that PrP C was up-regulated in fibrotic renal lesions
-
Vaccinology in the artificial intelligence era Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-16
Gianmarco Gasperini, Norman Baylor, Steve Black, David E. Bloom, Jakob Cramer, Gaël de Lannoy, Philippe Denoel, Mark Feinberg, Thibault Helleputte, Gagandeep Kang, William R. Schief, Lynda Stuart, Charlie Weller, Magda Zwierzyna, Rino RappuoliArtificial intelligence (AI) has already transformed vaccine antigen design and could transform the entire vaccinology pipeline, including immune responses and emerging infectious disease prediction, manufacturing and regulatory processes, clinical trial design and implementation, and vaccine access and equity. However, realizing the promise of AI for vaccinology requires more high-quality data.
-
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-16
Nicola Maciocia, Malika Hoekx, Ciaran Acuna, Brandon Wade, Amy Burley, Saumya Ramanayake, Francesco Nannini, Patrycja A. Wawrzyniecka, Thaneswari Karpanasamy, Maria Schuldt, Stephanie Ng, Mathieu Ferrari, Teresa Marafioti, Giuseppe Gritti, Shimobi Onuoha, David O’Connor, Lydia Lee, Marc Mansour, Asim Khwaja, Martin Pule, Paul MaciociaPatients with relapsed/refractory (r/r) T cell acute lymphoblastic leukemia (T-ALL) have a dismal prognosis, highlighting the urgent need for effective therapies. Chimeric antigen receptor (CAR)–T cell approaches targeting pan–T cell antigens may be limited by T cell aplasia and fratricide, necessitating “rescue” allogeneic hematopoietic stem cell transplantation. In this study, we identify CD21, a
-
-
Succinate-loaded tumor cell–derived microparticles reprogram tumor-associated macrophage metabolism Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-09
Shuya Lu, Jiexiao Li, Yonggang Li, Shichuan Liu, Yutong Liu, Yue Liang, Xifen Zheng, Yiyang Chen, Jinghui Deng, Huafeng Zhang, Jingwei Ma, Jiadi Lv, Yugang Wang, Bo Huang, Ke TangThe tumor microenvironment predominantly polarizes tumor-associated macrophages (TAMs) toward an M2-like phenotype, thereby inhibiting antitumor immune responses. This process is substantially affected by metabolic reprogramming; however, reeducating TAMs to enhance their antitumor capabilities through metabolic remodeling remains a challenge. Here, we show that tumor-derived microparticles loaded
-
The response to anti–PD-1 and anti–LAG-3 checkpoint blockade is associated with regulatory T cell reprogramming Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-09
Annah S. Rolig, Xiyu Peng, Elizabeth R. Sturgill, Nisha Holay, Melissa Kasiewicz, Courtney Mick, Grace Helen Mcgee, William Miller, Yoshinobu Koguchi, Johanna Kaufmann, Niranjan Yanamandra, Sue Griffin, James Smothers, Matthew Adamow, Jasme Lee, Ronglai Shen, Margaret K. Callahan, William L. RedmondImmune checkpoint blockade (ICB) has revolutionized cancer treatment; however, many patients develop therapeutic resistance. We previously identified and validated a pretreatment peripheral blood biomarker, characterized by a high frequency of LAG-3 + lymphocytes, that predicts resistance in patients receiving anti–PD-1 (aPD-1) ICB. To better understand the mechanism of aPD-1 resistance, we identified
-
The mRNA export pathway licenses viral mimicry response and antitumor immunity by actively exporting nuclear retroelement transcripts Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-09
Xiaoqiang Wang, Jiaxing Jin, Han Yan, Jinhua Liu, Shan Huang, Hui Bai, Mingrui Guo, Xinyue Cheng, Ting Deng, Yi Ba, Yong Gu, Xin Gao, Deqing HuNuclear retroelement transcripts (RTs), which can be elicited both transcriptionally and posttranscriptionally, form double-stranded RNA (dsRNA) in cytosol to trigger the viral mimicry response (VMR) and antitumor immunity. However, the strength of the induced VMR varies tremendously across tumor types, and the underlying mechanisms remain poorly understood. Here, we demonstrate that the mRNA export
-
Rapid tuberculosis diagnosis from respiratory or blood samples by a low cost, portable lab-in-tube assay Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-09
Brady M. Youngquist, Julian Saliba, Yelim Kim, Thomas J. Cutro, Christopher J. Lyon, Juan Olivo, Ngan Ha, Janelle Fine, Rebecca Colman, Carlos Vergara, James Robinson, Sylvia LaCourse, Richard S. Garfein, Donald G. Catanzaro, Christoph Lange, Eddy Perez-Then, Edward A. Graviss, Charles D. Mitchell, Timothy Rodwell, Bo Ning, Tony Y. HuRapid portable assays are needed to improve diagnosis, treatment, and reduce transmission of tuberculosis (TB), but current tests are not suitable for patients in resource-limited settings with high TB burden. Here we report a low complexity, lab-in-tube system that is read by an integrated handheld device that detects Mycobacterium tuberculosis ( Mtb ) DNA in blood and respiratory samples from a variety
-
Spatial genomics: Mapping the landscape of fibrosis Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-09
Prasad Palani Velu, Roxanna E. Abhari, Neil C. HendersonOrgan fibrosis causes major morbidity and mortality worldwide. Treatments for fibrosis are limited, with organ transplantation being the only cure. Here, we review how various state-of-the-art spatial genomics approaches are being deployed to interrogate fibrosis across multiple organs, providing exciting insights into fibrotic disease pathogenesis. These include the detailed topographical annotation
-
Collagen V regulates renal function after kidney injury and can be pharmacologically targeted to enhance kidney repair in mice Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-09
Lianjiu Su, Qihao Sun, Yusheng Li, Juan Felipe Alvarez, Bo Tao, Guanglin Zhang, Yiqian Gu, Mark R. Hanudel, Alejandro Espinoza, Linlin Zhang, Calvin Pan, James R. Hilser, Jaana A. Hartiala, Shen Li, Matteo Pellegrini, Hooman Allayee, Aldons J. Lusis, Arjun DebKidney fibrosis determines clinical outcomes in individuals with chronic kidney disease (CKD). The stoichiometric ratio of collagens in renal scar differs from that of healthy kidney extracellular matrix (ECM), but the functional importance of altered collagen types in injured kidneys remains unclear. Using human population studies, we show that circulating protein and renal mRNA amounts of collagen
-
Path to a cure for debilitating pregnancy sickness. Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-02
Marlena FejzoIdentification of GDF15 as a cause of severe nausea and vomiting during pregnancy is opening new doors for treatment and prevention.
-
Self-regulating gene therapy ameliorates phenotypes and overcomes gene dosage sensitivity in a mouse model of Rett syndrome Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-02
Paul D. Ross, Kamal K. E. Gadalla, Sophie R. Thomson, Jim Selfridge, Noha G. Bahey, Juliana Benito, Suzanne R. Burstein, Rachel McMinn, Brad Bolon, Ralph D. Hector, Stuart R. CobbConventional methods of gene transfer lead to inconsistent transgene expression within cells. This variability can be problematic, particularly in conditions like Rett syndrome (RTT), a neurological disorder caused by mutations in the MECP2 (methyl-CpG binding protein 2) gene, because overexpression of MECP2 can also cause adverse effects. To address these challenges, we devised a gene regulation system
-
Clinically compliant enrichment of human pluripotent stem cell–derived islets Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-02
Bahareh Rajaei, Amadeo Muñoz Garcia, Juri Juksar, Jason B. Doppenberg, Miriam Paz-Barba, Fransje Boot, Willemijn de Vos, Aat A. Mulder, Ferdy Lambregtse, Lizanne Daleman, Anne E. de Leeuw, Maaike C. Nieveen, Marten A. Engelse, Ton Rabelink, Eelco J. P. de Koning, Françoise CarlottiHuman pluripotent stem cell–derived islet (SC-islet) transplantation is a promising β cell replacement therapy for patients with type 1 diabetes, offering a potential unlimited cell supply. Yet, the heterogeneity of the final cell product containing non–target cell types has relevant implications for SC-islet function, transplant volume, and cell product safety. Here, we present a clinically compliant
-
Oligodendroglial precursor cells modulate immune response and early demyelination in a murine model of multiple sclerosis Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-02
Qi Wang, Taida Huang, Zihan Zheng, Yixun Su, Zhonghao Wu, Cong Zeng, Guangdan Yu, Yang Liu, Xiaorui Wang, Hui Li, Xiaoying Chen, Zhuoxu Jiang, Jinyu Zhang, Yuan Zhuang, Yi Tian, Qingwu Yang, Alexei Verkhratsky, Ying Wan, Chenju Yi, Jianqin NiuReproducing the pathophysiology of human multiple sclerosis (MS) in animal models is critical to identifying mechanisms triggering demyelination and to developing early intervention strategies. Here, we aimed to model overactivated Wnt (wingless-related integration site) signaling previously shown in postmortem brain tissues of patients with MS by inducing experimental autoimmune encephalomyelitis
-
Human iPSC–derived nephron progenitor cells treat acute kidney injury and chronic kidney disease in mouse models Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-02
Toshikazu Araoka, Kosuke Toyohara, Makoto Ryosaka, Chihiro Inui, Maasa Matsuura, Chen Ma, Jun Watahiki, Zhongwei Li, Mio Iwasaki, Akira Watanabe, Ryuji Yokokawa, Yasuhiko Tabata, Juan Carlos Izpisua Belmonte, Kenji OsafuneThe number of patients requiring dialysis therapy continues to increase worldwide because of the lack of effective treatments for chronic kidney disease (CKD). Furthermore, no curative treatments for acute kidney injury (AKI) have been established. The therapeutic effects of human induced pluripotent stem cell–derived nephron progenitor cells (hiPSC-NPCs) on AKI have been reported in mice but not clinically
-
Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trial Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-02
Baltazar Gomez-Mancilla, Kenneth M. Dürsteler, Marc Vogel, Marcus Herdener, Marta Torrens, Bartolomé P. Gálvez, Antoni Gual, Ricardo M. Corral, Enrique I. Kuper, Daniel L. Mosca, Swati Dumitras, Nicole Pezous, Maria Berkheimer, Ela Walker, Fabrizio Gasparini, Jang-Ho Cha, Ricardo DolmetschMetabotropic glutamate receptor 5 (mGluR5) is involved in cocaine reward processing and addiction. Preclinical studies suggest that blocking this receptor inhibits cocaine self-administration and seeking behavior in rodents. We assessed a selective noncompetitive antagonist of mGluR5 called mavoglurant in a phase 2 randomized, placebo-controlled clinical trial of 68 adults with cocaine use disorder
-
Ebola virus vaccination elicits Ebola virus–specific immune responses without substantial cross-reactivity to other filoviruses Sci. Transl. Med. (IF 15.8) Pub Date : 2025-04-02
Thembi Mdluli, Suzanne Wollen-Roberts, Mélanie Merbah, Bradley Beckman, Yifan Li, Aljawharah Alrubayyi, Daniel J. Curtis, Zhanna Shubin, Michael D. Barrera, Jacob Boeckelman, Shayla Duncan, Pallavi Thapa, Dohoon Kim, Margaret C. Costanzo, Hongjun Bai, Bethany L. Dearlove, Jay W. Hooper, Steven A. Kwilas, Dominic Paquin-Proulx, Michael A. Eller, Leigh Anne Eller, Hannah Kibuuka, Betty Mwesigwa, JosphatThe Janssen Ebola virus (EBOV) vaccine consists of the adenovirus type 26 vector encoding the EBOV glycoprotein (GP) (Ad26.ZEBOV) and the modified vaccinia Ankara (MVA) vector encoding GP from EBOV, Sudan virus, and Marburg virus and nucleoprotein from Tai Forest virus (MVA-BN-Filo) administered 8 weeks later. We conducted a systems immunology analysis of antibody-mediated and cellular immune responses